市場調査レポート
商品コード
1400427

痙縮治療の世界市場 2024-2028

Global Spasticity Treatment Market 2024-2028

出版日: | 発行: TechNavio | ページ情報: 英文 173 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
痙縮治療の世界市場 2024-2028
出版日: 2023年12月15日
発行: TechNavio
ページ情報: 英文 173 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

痙縮治療市場は2023-2028年に16億1,000万米ドル、予測期間中のCAGRは5.5%で成長すると予測されます。

当レポートでは、痙縮治療市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。慢性疾患や健康状態の増加、ドラッグデリバリーによる先端技術の利用可能性向上、ボツリヌス毒素やカンナビノイドのイントロダクションなどが市場を牽引しています。

市場範囲
基準年 2023
終了年 2028
予測期間 2024-2028
成長モメンタム 加速
前年比2024年 4.6%
CAGR 5.5%
増分額 16億1,000万米ドル

本調査では、痙縮治療向け神経刺激装置の登場が、今後数年間の痙縮治療市場の成長を牽引する主要因の1つであるとしています。また、痙縮治療の痙縮、遠隔医療、遠隔モニタリングに対する意識の高まりは、市場の大きな需要につながっています。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場エコシステム

第3章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2023
  • 市場の見通し 2023-2028

第4章 市場規模実績

  • 痙縮治療の世界市場 2018-2022
  • タイプセグメント分析 2018-2022
  • エンドユーザーセグメント分析 2018-2022
  • 地域別セグメント分析 2018-2022
  • 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第6章 市場セグメンテーション:タイプ別

  • 市場セグメント
  • 比較:タイプ別
  • 薬物療法:市場規模と予測 2023-2028
  • 理学療法:市場規模と予測 2023-2028
  • 外科的治療:市場規模と予測 2023-2028
  • 市場機会:タイプ別

第7章 市場セグメンテーション:エンドユーザー別

  • 市場セグメント
  • 比較:エンドユーザー別
  • 病院:市場規模と予測 2023-2028
  • 外来手術センター:市場規模と予測 2023-2028
  • 在宅医療:市場規模と予測 2023-2028
  • 専門クリニック:市場規模と予測 2023-2028
  • 診断センター:市場規模と予測 2023-2028
  • 市場機会:エンドユーザー別

第8章 顧客情勢

  • 顧客情勢の概要

第9章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測 2023-2028
  • 欧州:市場規模と予測 2023-2028
  • アジア:市場規模と予測 2023-2028
  • 世界のその他の地域:市場規模と予測 2023-2028
  • 米国:市場規模と予測 2023-2028
  • 中国:市場規模と予測 2023-2028
  • 英国:市場規模と予測 2023-2028
  • カナダ:市場規模と予測 2023-2028
  • ドイツ:市場規模と予測 2023-2028
  • 市場機会:地域別

第10章 促進要因、課題、および動向

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場動向

第11章 ベンダー情勢

  • 概要
  • ベンダー情勢
  • 混乱の状況
  • 業界のリスク

第12章 ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Abbott Laboratories
  • Axonics Inc.
  • Boston Scientific Corp.
  • BrainsWay Ltd.
  • electroCore Inc.
  • LivaNova Plc
  • Medtronic Plc
  • NEURONETICS Inc.
  • Nevro Corp.
  • OMRON Corp.
  • PathMaker Neurosystems Inc.
  • Saebo Inc
  • Saluda Medical Pty Ltd.
  • ShiraTronics
  • Theranica Bio Electronics Ltd.

第13章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market by Geography
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits18: Historic Market Size - Data Table on global spasticity treatment market 2018 - 2022 ($ billion)
  • Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
  • Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
  • Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
  • Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
  • Exhibits23: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits29: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits30: Chart on Type - Market share 2023-2028 (%)
  • Exhibits31: Data Table on Type - Market share 2023-2028 (%)
  • Exhibits32: Chart on Comparison by Type
  • Exhibits33: Data Table on Comparison by Type
  • Exhibits34: Chart on Drug therapy - Market size and forecast 2023-2028 ($ billion)
  • Exhibits35: Data Table on Drug therapy - Market size and forecast 2023-2028 ($ billion)
  • Exhibits36: Chart on Drug therapy - Year-over-year growth 2023-2028 (%)
  • Exhibits37: Data Table on Drug therapy - Year-over-year growth 2023-2028 (%)
  • Exhibits38: Chart on Physical therapy - Market size and forecast 2023-2028 ($ billion)
  • Exhibits39: Data Table on Physical therapy - Market size and forecast 2023-2028 ($ billion)
  • Exhibits40: Chart on Physical therapy - Year-over-year growth 2023-2028 (%)
  • Exhibits41: Data Table on Physical therapy - Year-over-year growth 2023-2028 (%)
  • Exhibits42: Chart on Surgical treatment - Market size and forecast 2023-2028 ($ billion)
  • Exhibits43: Data Table on Surgical treatment - Market size and forecast 2023-2028 ($ billion)
  • Exhibits44: Chart on Surgical treatment - Year-over-year growth 2023-2028 (%)
  • Exhibits45: Data Table on Surgical treatment - Year-over-year growth 2023-2028 (%)
  • Exhibits46: Market opportunity by Type ($ billion)
  • Exhibits47: Data Table on Market opportunity by Type ($ billion)
  • Exhibits48: Chart on End-user - Market share 2023-2028 (%)
  • Exhibits49: Data Table on End-user - Market share 2023-2028 (%)
  • Exhibits50: Chart on Comparison by End-user
  • Exhibits51: Data Table on Comparison by End-user
  • Exhibits52: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
  • Exhibits53: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
  • Exhibits54: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
  • Exhibits55: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
  • Exhibits56: Chart on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ billion)
  • Exhibits57: Data Table on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ billion)
  • Exhibits58: Chart on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%)
  • Exhibits59: Data Table on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%)
  • Exhibits60: Chart on Home care settings - Market size and forecast 2023-2028 ($ billion)
  • Exhibits61: Data Table on Home care settings - Market size and forecast 2023-2028 ($ billion)
  • Exhibits62: Chart on Home care settings - Year-over-year growth 2023-2028 (%)
  • Exhibits63: Data Table on Home care settings - Year-over-year growth 2023-2028 (%)
  • Exhibits64: Chart on Specialty clinics - Market size and forecast 2023-2028 ($ billion)
  • Exhibits65: Data Table on Specialty clinics - Market size and forecast 2023-2028 ($ billion)
  • Exhibits66: Chart on Specialty clinics - Year-over-year growth 2023-2028 (%)
  • Exhibits67: Data Table on Specialty clinics - Year-over-year growth 2023-2028 (%)
  • Exhibits68: Chart on Diagnostic centers - Market size and forecast 2023-2028 ($ billion)
  • Exhibits69: Data Table on Diagnostic centers - Market size and forecast 2023-2028 ($ billion)
  • Exhibits70: Chart on Diagnostic centers - Year-over-year growth 2023-2028 (%)
  • Exhibits71: Data Table on Diagnostic centers - Year-over-year growth 2023-2028 (%)
  • Exhibits72: Market opportunity by End-user ($ billion)
  • Exhibits73: Data Table on Market opportunity by End-user ($ billion)
  • Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits75: Chart on Market share by geography 2023-2028 (%)
  • Exhibits76: Data Table on Market share by geography 2023-2028 (%)
  • Exhibits77: Chart on Geographic comparison
  • Exhibits78: Data Table on Geographic comparison
  • Exhibits79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibits80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibits81: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits82: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibits84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibits85: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits87: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibits88: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibits89: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibits92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibits93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits95: Chart on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibits96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibits97: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits98: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits99: Chart on China - Market size and forecast 2023-2028 ($ billion)
  • Exhibits100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
  • Exhibits101: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits102: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibits104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibits105: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits106: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits107: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
  • Exhibits108: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
  • Exhibits109: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits110: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits111: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibits112: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibits113: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits114: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits115: Market opportunity by geography ($ billion)
  • Exhibits116: Data Tables on Market opportunity by geography ($ billion)
  • Exhibits117: Impact of drivers and challenges in 2023 and 2028
  • Exhibits118: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits119: Overview on factors of disruption
  • Exhibits120: Impact of key risks on business
  • Exhibits121: Vendors covered
  • Exhibits122: Matrix on vendor position and classification
  • Exhibits123: Abbott Laboratories - Overview
  • Exhibits124: Abbott Laboratories - Business segments
  • Exhibits125: Abbott Laboratories - Key news
  • Exhibits126: Abbott Laboratories - Key offerings
  • Exhibits127: Abbott Laboratories - Segment focus
  • Exhibits128: Axonics Inc. - Overview
  • Exhibits129: Axonics Inc. - Business segments
  • Exhibits130: Axonics Inc. - Key offerings
  • Exhibits131: Axonics Inc. - Segment focus
  • Exhibits132: Boston Scientific Corp. - Overview
  • Exhibits133: Boston Scientific Corp. - Business segments
  • Exhibits134: Boston Scientific Corp. - Key news
  • Exhibits135: Boston Scientific Corp. - Key offerings
  • Exhibits136: Boston Scientific Corp. - Segment focus
  • Exhibits137: BrainsWay Ltd. - Overview
  • Exhibits138: BrainsWay Ltd. - Product / Service
  • Exhibits139: BrainsWay Ltd. - Key offerings
  • Exhibits140: electroCore Inc. - Overview
  • Exhibits141: electroCore Inc. - Product / Service
  • Exhibits142: electroCore Inc. - Key offerings
  • Exhibits143: LivaNova Plc - Overview
  • Exhibits144: LivaNova Plc - Business segments
  • Exhibits145: LivaNova Plc - Key offerings
  • Exhibits146: LivaNova Plc - Segment focus
  • Exhibits147: Medtronic Plc - Overview
  • Exhibits148: Medtronic Plc - Business segments
  • Exhibits149: Medtronic Plc - Key news
  • Exhibits150: Medtronic Plc - Key offerings
  • Exhibits151: Medtronic Plc - Segment focus
  • Exhibits152: NEURONETICS Inc. - Overview
  • Exhibits153: NEURONETICS Inc. - Product / Service
  • Exhibits154: NEURONETICS Inc. - Key offerings
  • Exhibits155: Nevro Corp. - Overview
  • Exhibits156: Nevro Corp. - Product / Service
  • Exhibits157: Nevro Corp. - Key offerings
  • Exhibits158: OMRON Corp. - Overview
  • Exhibits159: OMRON Corp. - Business segments
  • Exhibits160: OMRON Corp. - Key news
  • Exhibits161: OMRON Corp. - Key offerings
  • Exhibits162: OMRON Corp. - Segment focus
  • Exhibits163: PathMaker Neurosystems Inc. - Overview
  • Exhibits164: PathMaker Neurosystems Inc. - Product / Service
  • Exhibits165: PathMaker Neurosystems Inc. - Key offerings
  • Exhibits166: Saebo Inc - Overview
  • Exhibits167: Saebo Inc - Product / Service
  • Exhibits168: Saebo Inc - Key offerings
  • Exhibits169: Saluda Medical Pty Ltd. - Overview
  • Exhibits170: Saluda Medical Pty Ltd. - Product / Service
  • Exhibits171: Saluda Medical Pty Ltd. - Key offerings
  • Exhibits172: ShiraTronics - Overview
  • Exhibits173: ShiraTronics - Product / Service
  • Exhibits174: ShiraTronics - Key offerings
  • Exhibits175: Theranica Bio Electronics Ltd. - Overview
  • Exhibits176: Theranica Bio Electronics Ltd. - Product / Service
  • Exhibits177: Theranica Bio Electronics Ltd. - Key offerings
  • Exhibits178: Inclusions checklist
  • Exhibits179: Exclusions checklist
  • Exhibits180: Currency conversion rates for US$
  • Exhibits181: Research methodology
  • Exhibits182: Validation techniques employed for market sizing
  • Exhibits183: Information sources
  • Exhibits184: List of abbreviations
目次
Product Code: IRTNTR72357

Abstract

The spasticity treatment market is forecasted to grow by USD 1.61 bn during 2023-2028, accelerating at a CAGR of 5.5% during the forecast period. The report on the spasticity treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing incidence of chronic diseases and health conditions, the availability of advanced technologies for drug delivery, and the introduction of botulinum toxins and cannabinoids.

Market Scope
Base Year2023
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20244.6%
CAGR5.5%
Incremental Value$1.61bn

Technavio's spasticity treatment market is segmented as below:

By Type

  • Drug therapy
  • Physical therapy
  • Surgical treatment

By End-user

  • Hospitals
  • Ambulatory surgical centers
  • Home care settings
  • Specialty clinics
  • Diagnostic centers

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the advent of neurostimulation devices for spasticity treatment as one of the prime reasons driving the spasticity treatment market growth during the next few years. Also, growing awareness of spasticity and telemedicine and remote monitoring for spasticity treatment will lead to sizable demand in the market.

The report on the spasticity treatment market covers the following areas:

  • Spasticity treatment market sizing
  • Spasticity treatment market forecast
  • Spasticity treatment market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading spasticity treatment market vendors that include Abbott Laboratories, Axonics Inc., BioWave Ltd., Boston Scientific Corp., BrainsWay Ltd., electroCore Inc., LivaNova Plc, Mayo Clinic, Medtronic Plc, NEURONETICS Inc., Nevro Corp., OMRON Corp., PathMaker Neurosystems Inc., Rady Childrens Hospital San Diego, Saebo Inc, Saluda Medical Pty Ltd., ShiraTronics, The Johns Hopkins Health System Corp., Theranica Bio Electronics Ltd., and Thync Global Inc.. Also, the spasticity treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape and an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market by Geography
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
  • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global spasticity treatment market 2018 - 2022
  • Exhibit 18: Historic Market Size - Data Table on global spasticity treatment market 2018 - 2022 ($ billion)
  • 4.2 Type Segment Analysis 2018 - 2022
  • Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
  • 4.3 End-user Segment Analysis 2018 - 2022
  • Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
  • 4.4 Geography Segment Analysis 2018 - 2022
  • Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
  • 4.5 Country Segment Analysis 2018 - 2022
  • Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

  • 6.1 Market segments
  • Exhibit 30: Chart on Type - Market share 2023-2028 (%)
  • Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
  • 6.2 Comparison by Type
  • Exhibit 32: Chart on Comparison by Type
  • Exhibit 33: Data Table on Comparison by Type
  • 6.3 Drug therapy - Market size and forecast 2023-2028
  • Exhibit 34: Chart on Drug therapy - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 35: Data Table on Drug therapy - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 36: Chart on Drug therapy - Year-over-year growth 2023-2028 (%)
  • Exhibit 37: Data Table on Drug therapy - Year-over-year growth 2023-2028 (%)
  • 6.4 Physical therapy - Market size and forecast 2023-2028
  • Exhibit 38: Chart on Physical therapy - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 39: Data Table on Physical therapy - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 40: Chart on Physical therapy - Year-over-year growth 2023-2028 (%)
  • Exhibit 41: Data Table on Physical therapy - Year-over-year growth 2023-2028 (%)
  • 6.5 Surgical treatment - Market size and forecast 2023-2028
  • Exhibit 42: Chart on Surgical treatment - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 43: Data Table on Surgical treatment - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 44: Chart on Surgical treatment - Year-over-year growth 2023-2028 (%)
  • Exhibit 45: Data Table on Surgical treatment - Year-over-year growth 2023-2028 (%)
  • 6.6 Market opportunity by Type
  • Exhibit 46: Market opportunity by Type ($ billion)
  • Exhibit 47: Data Table on Market opportunity by Type ($ billion)

7 Market Segmentation by End-user

  • 7.1 Market segments
  • Exhibit 48: Chart on End-user - Market share 2023-2028 (%)
  • Exhibit 49: Data Table on End-user - Market share 2023-2028 (%)
  • 7.2 Comparison by End-user
  • Exhibit 50: Chart on Comparison by End-user
  • Exhibit 51: Data Table on Comparison by End-user
  • 7.3 Hospitals - Market size and forecast 2023-2028
  • Exhibit 52: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 53: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 54: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
  • Exhibit 55: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
  • 7.4 Ambulatory surgical centers - Market size and forecast 2023-2028
  • Exhibit 56: Chart on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 57: Data Table on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 58: Chart on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%)
  • Exhibit 59: Data Table on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%)
  • 7.5 Home care settings - Market size and forecast 2023-2028
  • Exhibit 60: Chart on Home care settings - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 61: Data Table on Home care settings - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 62: Chart on Home care settings - Year-over-year growth 2023-2028 (%)
  • Exhibit 63: Data Table on Home care settings - Year-over-year growth 2023-2028 (%)
  • 7.6 Specialty clinics - Market size and forecast 2023-2028
  • Exhibit 64: Chart on Specialty clinics - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 65: Data Table on Specialty clinics - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 66: Chart on Specialty clinics - Year-over-year growth 2023-2028 (%)
  • Exhibit 67: Data Table on Specialty clinics - Year-over-year growth 2023-2028 (%)
  • 7.7 Diagnostic centers - Market size and forecast 2023-2028
  • Exhibit 68: Chart on Diagnostic centers - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 69: Data Table on Diagnostic centers - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 70: Chart on Diagnostic centers - Year-over-year growth 2023-2028 (%)
  • Exhibit 71: Data Table on Diagnostic centers - Year-over-year growth 2023-2028 (%)
  • 7.8 Market opportunity by End-user
  • Exhibit 72: Market opportunity by End-user ($ billion)
  • Exhibit 73: Data Table on Market opportunity by End-user ($ billion)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 75: Chart on Market share by geography 2023-2028 (%)
  • Exhibit 76: Data Table on Market share by geography 2023-2028 (%)
  • 9.2 Geographic comparison
  • Exhibit 77: Chart on Geographic comparison
  • Exhibit 78: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
  • Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 9.4 Europe - Market size and forecast 2023-2028
  • Exhibit 83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibit 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 9.5 Asia - Market size and forecast 2023-2028
  • Exhibit 87: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 88: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 89: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibit 90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 9.7 US - Market size and forecast 2023-2028
  • Exhibit 95: Chart on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 97: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibit 98: Data Table on US - Year-over-year growth 2023-2028 (%)
  • 9.8 China - Market size and forecast 2023-2028
  • Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
  • 9.9 UK - Market size and forecast 2023-2028
  • Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 9.10 Canada - Market size and forecast 2023-2028
  • Exhibit 107: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 108: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 109: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibit 110: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • 9.11 Germany - Market size and forecast 2023-2028
  • Exhibit 111: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 112: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 113: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibit 114: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 9.12 Market opportunity by geography
  • Exhibit 115: Market opportunity by geography ($ billion)
  • Exhibit 116: Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 117: Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 119: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 120: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 121: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 122: Matrix on vendor position and classification
  • 12.3 Abbott Laboratories
  • Exhibit 123: Abbott Laboratories - Overview
  • Exhibit 124: Abbott Laboratories - Business segments
  • Exhibit 125: Abbott Laboratories - Key news
  • Exhibit 126: Abbott Laboratories - Key offerings
  • Exhibit 127: Abbott Laboratories - Segment focus
  • 12.4 Axonics Inc.
  • Exhibit 128: Axonics Inc. - Overview
  • Exhibit 129: Axonics Inc. - Business segments
  • Exhibit 130: Axonics Inc. - Key offerings
  • Exhibit 131: Axonics Inc. - Segment focus
  • 12.5 Boston Scientific Corp.
  • Exhibit 132: Boston Scientific Corp. - Overview
  • Exhibit 133: Boston Scientific Corp. - Business segments
  • Exhibit 134: Boston Scientific Corp. - Key news
  • Exhibit 135: Boston Scientific Corp. - Key offerings
  • Exhibit 136: Boston Scientific Corp. - Segment focus
  • 12.6 BrainsWay Ltd.
  • Exhibit 137: BrainsWay Ltd. - Overview
  • Exhibit 138: BrainsWay Ltd. - Product / Service
  • Exhibit 139: BrainsWay Ltd. - Key offerings
  • 12.7 electroCore Inc.
  • Exhibit 140: electroCore Inc. - Overview
  • Exhibit 141: electroCore Inc. - Product / Service
  • Exhibit 142: electroCore Inc. - Key offerings
  • 12.8 LivaNova Plc
  • Exhibit 143: LivaNova Plc - Overview
  • Exhibit 144: LivaNova Plc - Business segments
  • Exhibit 145: LivaNova Plc - Key offerings
  • Exhibit 146: LivaNova Plc - Segment focus
  • 12.9 Medtronic Plc
  • Exhibit 147: Medtronic Plc - Overview
  • Exhibit 148: Medtronic Plc - Business segments
  • Exhibit 149: Medtronic Plc - Key news
  • Exhibit 150: Medtronic Plc - Key offerings
  • Exhibit 151: Medtronic Plc - Segment focus
  • 12.10 NEURONETICS Inc.
  • Exhibit 152: NEURONETICS Inc. - Overview
  • Exhibit 153: NEURONETICS Inc. - Product / Service
  • Exhibit 154: NEURONETICS Inc. - Key offerings
  • 12.11 Nevro Corp.
  • Exhibit 155: Nevro Corp. - Overview
  • Exhibit 156: Nevro Corp. - Product / Service
  • Exhibit 157: Nevro Corp. - Key offerings
  • 12.12 OMRON Corp.
  • Exhibit 158: OMRON Corp. - Overview
  • Exhibit 159: OMRON Corp. - Business segments
  • Exhibit 160: OMRON Corp. - Key news
  • Exhibit 161: OMRON Corp. - Key offerings
  • Exhibit 162: OMRON Corp. - Segment focus
  • 12.13 PathMaker Neurosystems Inc.
  • Exhibit 163: PathMaker Neurosystems Inc. - Overview
  • Exhibit 164: PathMaker Neurosystems Inc. - Product / Service
  • Exhibit 165: PathMaker Neurosystems Inc. - Key offerings
  • 12.14 Saebo Inc
  • Exhibit 166: Saebo Inc - Overview
  • Exhibit 167: Saebo Inc - Product / Service
  • Exhibit 168: Saebo Inc - Key offerings
  • 12.15 Saluda Medical Pty Ltd.
  • Exhibit 169: Saluda Medical Pty Ltd. - Overview
  • Exhibit 170: Saluda Medical Pty Ltd. - Product / Service
  • Exhibit 171: Saluda Medical Pty Ltd. - Key offerings
  • 12.16 ShiraTronics
  • Exhibit 172: ShiraTronics - Overview
  • Exhibit 173: ShiraTronics - Product / Service
  • Exhibit 174: ShiraTronics - Key offerings
  • 12.17 Theranica Bio Electronics Ltd.
  • Exhibit 175: Theranica Bio Electronics Ltd. - Overview
  • Exhibit 176: Theranica Bio Electronics Ltd. - Product / Service
  • Exhibit 177: Theranica Bio Electronics Ltd. - Key offerings

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 178: Inclusions checklist
  • Exhibit 179: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 180: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 181: Research methodology
  • Exhibit 182: Validation techniques employed for market sizing
  • Exhibit 183: Information sources
  • 13.5 List of abbreviations
  • Exhibit 184: List of abbreviations